{
  "ptid_time": "032_S_4277_2011-10-19",
  "img_path": "/data/qiuhui/data/adni/images/032_S_4277/2011-10-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 13,843 mm³, 50.7% below the reference mean. With a Z-score of -1.16 (12.3th percentile), this represents mild atrophy; hippocampal volume measures 5,859 mm³, 17.6% below the reference mean. With a Z-score of -1.62 (5.3th percentile), this represents moderate atrophy; whole brain volume measures 932,238 mm³, 4.4% below the reference mean. With a Z-score of -0.55 (29.2th percentile), this represents normal volume ; entorhinal cortex volume measures 2,260 mm³, 38.5% below the reference mean. With a Z-score of -2.36 (0.9th percentile), this represents significant atrophy; fusiform gyrus volume measures 18,060 mm³, 6.2% above the reference mean. With a Z-score of 0.56 (71.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,805 mm³, 7.1% below the reference mean. With a Z-score of -0.62 (26.8th percentile), this represents normal volume . ",
  "text_data": "Age is 71.4 years. Gender is Female. Education: 18 years. Handedness: Right. Race: Black or African American. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Gastrointestinal; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 28.0. MoCA: 29.0. Logical Memory: 15.0. Laboratory findings: . APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.36 SUVR (significant elevated); Total tau: 232.00 pg/mL (normal ); Phosphorylated tau: 19.70 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the entorhinal cortex (Z-score -2.36, 0.9th percentile) and moderate hippocampal atrophy (Z-score -1.62, 5.3th percentile), both of which are early markers of Alzheimer’s pathology. However, cognitive scores (MMSE 28, MoCA 29) remain intact, and CSF biomarkers (T-tau, P-tau) are normal despite elevated amyloid (AV45).  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (Cognitive scores are preserved, but structural atrophy and amyloid positivity suggest early neurodegenerative changes. The absence of APOE4 and normal tau levels reduce certainty.)  \n\n*Note: Follow-up cognitive testing and longitudinal imaging would help clarify progression.*",
  "timestamp": "2025-07-26T05:03:24.078511"
}